Onconova Therapeutics Announces Proposed Public Offering of Common Stock
NEWTOWN, Pa., April 20, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer, with a primary focus on …